Thor Björgolfsson is a self-styled “adventure capitalist”, who became Iceland’s first billionaire. He made his first fortune with Bravo Brewery in St Petersburg, Russia, selling it to Heineken in 2002. Over the next years he invested in telecoms, mostly in Eastern Europe, built up generic drugs company Actavis (now Allergan) and became big investor in one of Iceland’s largest banks, Landsbanki. Thor continues to be an active investor in the emerging economies of Central and Eastern Europe and Latin America through his London-based private equity fund Novator Partners LLP. He is Chairman of Novator and maintains a shareholding in companies including telecoms Play in Poland and WOM in Chile, as well as computer games company CCP, data center Verne Global and pharmaceutical company Xantis Pharma. Thor graduated from New York University‘s Stern School of Business with a degree in Finance and has served on the School‘s Board of Overseers for the past 8 years. Thor’s autobiography, “Billions to Bust—and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way”, was published in 2014.